The new technology — CoverEdge Surgical Leads — is designed for use with the Precision Spectra Spinal Cord Stimulation System. The system treats chronic back pain patients by interrupting pain signals with electric pulses.
“The technology is unique and can individualize the therapeutic signal down to a single contact to really pinpoint the therapy,” said Dr. Jones-Quaidoo. “We are talking about potentially hitting a bull’s eye in obtaining pain relief.”
The CoverEdge technology received FDA clearance late last year and is the world’s first and only 32-contract surgical leads. The technology blankets the spinal cord with twice the number of contracts traditional systems offer. The leads can also be used in conjunction with the Illumina 3D software for more precise pain targeting.
More articles on spine treatment:
Titanium spinal implants? 5 key points on effectiveness
Blood transfusion for pediatric spinal fusion: What factors make an impact? 5 things to know
Scoliosis surgery: JAZZ vs. Universal Clamp—5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.